Treace Medical Concepts (TMCI) Change in Receivables (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Change in Receivables came in at -$11.7 million in Q1 2026, down 25.79% YoY from -$15.7 million in Q1 2025, and down 222.77% on a QoQ basis from $9.5 million in Q4 2025.
Treace Medical Concepts (TMCI) Change in Receivables (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Change in Receivables data on file, last reported at -$11.7 million in Q1 2026.
- Quarterly Change in Receivables fell 25.79% year-over-year to -$11.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$306000.0 (down 107.25% YoY) and the FY2025 annual result came in at $2.1 million, down 63.25% from the prior year.
- Change in Receivables eased to -$11.7 million in Q1 2026, from $9.5 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $17.2 million in Q4 2024 to a low of -$11.7 million in Q1 2026.
- A 5-year average of $966588.2 and a median of -$696000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables jumped 343.49% — and 2024, when it slumped 229.84%.
- Tracing TMCI's Change in Receivables over 5 years: stood at $11.1 million in 2022, then advanced by 20.95% to $13.4 million in 2023, then increased by 28.09% to $17.2 million in 2024, then plunged by 44.64% to $9.5 million in 2025, then slumped by 222.77% to -$11.7 million in 2026.
- The last three Change in Receivables figures came in at -$11.7 million (Q1 2026), $9.5 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Treace Medical Concepts | 283.62 Mn | 238.00 Mn | 35.61 Mn | -1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.50 Mn |
| Jun 30, 2026 | -1.50 Mn |
| Mar 31, 2026 | -11.69 Mn |
| Mar 31, 2026 | -11.69 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Dec 31, 2025 | 9.52 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | -696,000.00 |
| Jun 30, 2025 | -696,000.00 |
| Mar 31, 2025 | -9.29 Mn |
| Mar 31, 2025 | -9.29 Mn |
| Dec 31, 2024 | 17.19 Mn |
| Dec 31, 2024 | 17.19 Mn |
| Sep 30, 2024 | -1.21 Mn |
| Sep 30, 2024 | -1.21 Mn |
| Jun 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | -2.48 Mn |
| Mar 31, 2024 | -7.82 Mn |
| Mar 31, 2024 | -7.82 Mn |